Profile data is unavailable for this security.
About the company
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
- Revenue in USD (TTM)2.86bn
- Net income in USD-1.76bn
- Incorporated2021
- Employees7.10k
- LocationQuidelOrtho Corp9975 Summers Ridge RoadSAN DIEGO 92121United StatesUSA
- Phone+1 (858) 552-1100
- Fax+1 (858) 453-4338
- Websitehttps://www.quidelortho.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alignment Healthcare Inc | 2.01bn | -157.25m | 1.59bn | 1.54k | -- | 12.15 | -- | 0.7902 | -0.837 | -0.837 | 10.73 | 0.6849 | 2.89 | -- | 13.87 | 1,310,596.00 | -22.56 | -- | -45.76 | -- | 10.61 | -- | -7.82 | -- | -- | -6.19 | 0.551 | -- | 27.16 | -- | 1.02 | -- | -- | -- |
Veracyte Inc | 375.47m | -68.18m | 1.60bn | 815.00 | -- | 1.43 | -- | 4.27 | -0.9346 | -0.9346 | 5.12 | 14.64 | 0.3186 | 7.47 | 8.15 | 460,703.10 | -5.78 | -6.33 | -6.08 | -6.69 | 68.54 | 67.10 | -18.16 | -20.99 | 4.69 | -- | 0.00009 | -- | 21.76 | 31.45 | -103.51 | -- | 39.67 | -- |
NeoGenomics, Inc. | 610.66m | -84.23m | 1.68bn | 2.10k | -- | 1.82 | -- | 2.76 | -0.6698 | -0.6698 | 4.86 | 7.25 | 0.3646 | 15.88 | 4.69 | 290,791.90 | -5.03 | -3.57 | -5.29 | -3.80 | 41.80 | 41.09 | -13.79 | -9.36 | 7.22 | -- | 0.3685 | -- | 16.07 | 16.41 | 39.02 | -- | 14.98 | -- |
Teladoc Health Inc | 2.62bn | -233.03m | 1.70bn | 5.60k | -- | 0.7397 | 12.83 | 0.6475 | -1.40 | -1.40 | 15.80 | 13.52 | 0.607 | 19.58 | 12.18 | 467,732.50 | -5.40 | -33.54 | -5.93 | -34.63 | 70.81 | 68.59 | -8.90 | -171.39 | 3.74 | -- | 0.4021 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
Brightspring Health Services Inc | -100.00bn | -100.00bn | 1.79bn | 35.00k | -- | 1.14 | -- | -- | -- | -- | -- | 9.16 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 17.75 | -- | -0.6289 | 0.9631 | -- | 0.6229 | -- | 14.32 | 28.33 | -186.80 | -- | 17.24 | -- |
Addus Homecare Corporation | 1.09bn | 65.67m | 1.91bn | 6.06k | 28.93 | 2.63 | 23.88 | 1.75 | 4.02 | 4.02 | 66.67 | 44.30 | 1.12 | -- | 9.45 | 179,534.30 | 6.75 | 5.18 | 7.82 | 6.04 | 32.12 | 30.88 | 6.04 | 4.96 | -- | 10.02 | 0.1205 | 0.00 | 11.31 | 15.43 | 35.83 | 30.83 | 12.06 | -- |
Astrana Health Inc | 1.45bn | 62.42m | 1.93bn | 1.80k | 29.81 | 2.87 | 23.90 | 1.33 | 1.32 | 1.32 | 30.85 | 13.77 | 1.31 | -- | 8.64 | 807,652.30 | 5.61 | 7.09 | 6.61 | 9.39 | 16.58 | 18.30 | 4.28 | 6.36 | -- | 61.71 | 0.4635 | 10.54 | 21.19 | 21.68 | 34.42 | 41.16 | 89.42 | -- |
Lifestance Health Group Inc | 1.10bn | -173.12m | 2.02bn | 6.87k | -- | 1.41 | -- | 1.83 | -0.4671 | -0.4671 | 2.97 | 3.74 | 0.5175 | -- | 7.50 | 118,339.20 | -8.12 | -- | -8.93 | -- | -- | -- | -15.69 | -- | -- | -4.69 | 0.1652 | -- | 22.82 | -- | 13.59 | -- | -- | -- |
Privia Health Group Inc | 1.69bn | 18.74m | 2.08bn | 1.10k | 116.34 | 3.59 | 84.41 | 1.24 | 0.1502 | 0.1502 | 13.51 | 4.86 | 1.77 | -- | 5.56 | 1,530,584.00 | 1.85 | -- | 3.20 | -- | 9.67 | 9.15 | 1.05 | -2.56 | -- | -- | 0.00 | -- | 22.19 | 20.31 | 368.83 | -- | -12.48 | -- |
Quidelortho Corp | 2.86bn | -1.76bn | 2.44bn | 7.10k | -- | 0.7361 | -- | 0.8527 | -26.38 | -26.38 | 42.82 | 49.52 | 0.3696 | 2.67 | 8.92 | 403,197.20 | -22.79 | 11.34 | -25.57 | 12.91 | 48.13 | 62.71 | -61.65 | 20.93 | 0.807 | 0.8786 | 0.4207 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
Evolent Health Inc | 2.18bn | -141.23m | 2.52bn | 4.70k | -- | 2.37 | -- | 1.16 | -1.25 | -1.25 | 19.28 | 10.72 | 0.8316 | -- | 6.30 | 462,948.70 | -4.22 | -9.60 | -5.36 | -12.59 | 20.56 | 24.50 | -5.07 | -13.66 | -- | -0.0548 | 0.3272 | -- | 45.26 | 25.65 | -660.71 | -- | -6.18 | -- |
Progyny Inc | 1.11bn | 61.26m | 2.57bn | 563.00 | 44.44 | 4.54 | 40.32 | 2.32 | 0.6071 | 0.6071 | 10.98 | 5.95 | 1.53 | -- | 3.63 | 1,968,529.00 | 8.48 | 11.50 | 11.88 | 16.02 | 21.89 | 21.48 | 5.53 | 6.64 | -- | -- | 0.00 | 0.00 | 38.34 | 59.52 | 104.35 | -- | 44.47 | -- |
Agilon Health Inc | 4.78bn | -207.85m | 2.84bn | 1.12k | -- | 4.11 | -- | 0.5931 | -0.5182 | -0.71 | 11.78 | 1.68 | 2.13 | -- | 3.71 | 4,283,411.00 | -9.27 | -- | -20.91 | -- | 6.37 | -- | -4.35 | -- | -- | -- | 0.0514 | -- | 80.74 | -- | -112.01 | -- | -- | -- |
Irhythm Technologies Inc | 513.17m | -129.96m | 2.93bn | 2.00k | -- | 32.49 | -- | 5.72 | -4.22 | -4.22 | 16.71 | 2.90 | 0.7709 | 10.85 | 7.37 | 256,587.00 | -19.52 | -21.92 | -22.55 | -26.77 | 66.96 | 69.39 | -25.33 | -25.75 | 6.95 | -18.44 | 0.877 | -- | 19.90 | 27.32 | -6.24 | -- | 50.82 | -- |
Amedisys Inc | 2.25bn | -20.59m | 3.00bn | 19.00k | -- | 2.76 | 986.97 | 1.33 | -0.6446 | -0.6446 | 68.73 | 33.30 | 1.12 | -- | 6.89 | 118,495.10 | -1.05 | 7.82 | -1.38 | 10.39 | 44.39 | 43.63 | -0.9439 | 5.89 | -- | 11.62 | 0.2561 | 0.00 | 0.593 | 6.11 | -108.22 | -- | 14.16 | -- |
Surgery Partners Inc | 2.79bn | 600.00k | 3.18bn | 10.50k | 8,223.69 | 1.62 | 11.49 | 1.14 | 0.003 | 0.003 | 22.14 | 15.48 | 0.4104 | 24.89 | 5.90 | 266,142.80 | 2.33 | 1.17 | 3.20 | 1.63 | 33.73 | 26.33 | 5.67 | 3.03 | 1.56 | 2.47 | 0.4606 | -- | 8.03 | 9.14 | 78.21 | -- | 17.41 | -- |
Holder | Shares | % Held |
---|---|---|
T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 9.70m | 14.48% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 4.79m | 7.16% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 4.39m | 6.56% |
Rubric Capital Management LPas of 31 Mar 2024 | 2.40m | 3.58% |
ArrowMark Colorado Holdings LLCas of 31 Mar 2024 | 2.35m | 3.51% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.58m | 2.37% |
Dimensional Fund Advisors LPas of 31 Mar 2024 | 1.42m | 2.13% |
Maverick Capital Ltd.as of 31 Mar 2024 | 1.36m | 2.03% |
JPMorgan Investment Management, Inc.as of 31 Mar 2024 | 1.20m | 1.79% |
JANA Partners Management LPas of 31 Mar 2024 | 1.20m | 1.79% |